Angina, a chest pain stemming from reduced heart blood flow, often signals underlying heart issues like coronary artery ...

Topline results from the SURPASS-CVOT trial show that once-weekly tirzepatide has a cardiovascular risk profile similar to ...

Treating coronary artery disease will involve a personalised treatment plan consisting of lifestyle changes and a combination of medications. Learn more here.

Microvascular angina is characterized by chest pain, an abnormal stress test, and abnormal myocardial perfusion and metabolism in the setting of an otherwise normal coronary arteriogram.

Invasive coronary functional testing to identify the cause of angina in patients with nonobstructive coronary artery disease (ANOCA) can be performed safely at both experienced and less-experienced ...

Although the group with microvascular spasm was too small for provocation dose subgroup analyses, we did see a trend towards an inverse relationship between provocation dosage and angina frequency and ...

CORONARY microvascular dysfunction and myocardial endotypes of ischaemia with no obstructive coronary arteries (INOCA) are significantly associated with cumulative atherosclerotic plaque burden, as ...

This was then correlated with the Gensini score, a quantitative measure of coronary plaque burden. Novel measures of coronary microvascular dysfunction, including reduced microvascular resistance ...

The life expectancy for CAD depends on various factors, such as age, other comorbidities, how well treatment works, and healthy lifestyle changes.

MONDAY, Nov. 11, 2024 (HealthDay News) -- Recurring angina chest pain in people with a certain type of heart disease can be tough to treat, but a new hourglass-shaped stent could be a real advance, ...

Microvascular disease is a condition in which tiny blood vessels in the heart are not working properly, resulting in reduced blood flow to the heart. The resulting chest pains, or angina, can be ...